Basis: Current FMP quote-based enterprise value / matching reported total assets. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Assets ratio is 308.16x as of 2026-10-06T19:38:13.638Z.
Calculation as of: 2026-10-06T19:38:13.638Z.
Quote observation: 2026-10-06T19:34:34.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 680db3c2305e98602fe5277f15244516f30a0ab53cbf5830e5b41f5092839f7c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/ASSETS RATIO
308.16x
SECTOR MEDIAN · HEALTHCARE
1.58x
median of 781 covered companies
CURRENT VS SECTOR MEDIAN
+19403.80%
vs the sector median at left
SL Science Holding Ltd
Market Cap
$869.18M
EV/Assets Ratio
308.16x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$872.01M
EV/Assets Ratio
1.68x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$881.69M
EV/Assets Ratio
3.61x
TTM Avg
9.68x
3Y Avg
5.76x
5Y Avg
3.70x
Market Cap
$854.88M
EV/Assets Ratio
1.60x
TTM Avg
2.07x
3Y Avg
2.15x
5Y Avg
2.13x
Market Cap
$852.84M
EV/Assets Ratio
0.67x
TTM Avg
0.71x
3Y Avg
0.74x
5Y Avg
0.94x
Market Cap
$890.90M
EV/Assets Ratio
3.19x
TTM Avg
6.41x
3Y Avg
4.83x
5Y Avg
3.58x
| NAME | MARKET CAP | EV/ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SL Science Holding Ltd (SLBT) | $869.18M | 308.16x | N/A | N/A | N/A |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $872.01M | 1.68x | N/A | N/A | N/A |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $881.69M | 3.61x | 9.68x | 5.76x | 3.70x |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $854.88M | 1.60x | 2.07x | 2.15x | 2.13x |
| SI-BONE, Inc. (SIBN)vs › | $853.28M | 3.33x | 2.94x | 2.91x | 3.27x |
| QuidelOrtho Corporation (QDEL)vs › | $852.84M | 0.67x | 0.71x | 0.74x | 0.94x |
| Bioventus Inc. (BVS)vs › | $886.14M | 1.66x | 1.37x | 1.17x | 0.98x |
| Arbutus Biopharma Corp (ABUS)vs › | $890.90M | 3.19x | 6.41x | 4.83x | 3.58x |
| Alumis Inc. (ALMS)vs › | $843.04M | 1.46x | 3.92x | 2.29x | 2.29x |
| Pacific Biosciences of California, Inc. (PACB)vs › | $840.18M | 1.98x | 1.47x | 1.19x | 1.39x |
EV/Assets compares enterprise value to total assets. It is useful for asset-heavy businesses and for comparing how much the market pays for each dollar of assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
